|
Post by centralcoastinvestor on Jan 5, 2016 15:34:47 GMT -5
As others have said, no rose colored glasses today. This hurts. Bad. Now if I were Al Mann, I would be seething angry. Sanofi sandbagged him and Mannkind shareholders. Plain and simple. So I have a new dream. First, we survive. I think we will with Al Mann's help. Time to sue Sanofi for not living up to their end of the deal. Second, if we survive, then there is a new mission. A new dream. A new hope. TAKE MARKET SHARE FROM SANOFI! I hope we stick it to them but good over the years. I hope Mannkind becomes an ever present nightmare for Sanofi. I have a dream....
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 5, 2016 15:40:22 GMT -5
I can see Sanofi losing lots of market share to other basals - Tresiba and Lantus generic. They are were called a diabetes powerhouse cos of Lantus. Now they will know
|
|
|
Post by slugworth008 on Jan 5, 2016 15:40:44 GMT -5
As others have said, no rose colored glasses today. This hurts. Bad. Now if I were Al Mann, I would be seething angry. Sanofi sandbagged him and Mannkind shareholders. Plain and simple. So I have a new dream. First, we survive. I think we will with Al Mann's help. Time to sue Sanofi for not living up to their end of the deal. Second, if we survive, then there is a new mission. A new dream. A new hope. TAKE MARKET SHARE FROM SANOFI! I hope we stick it to them but good over the years. I hope Mannkind becomes an ever present nightmare for Sanofi. I have a dream.... YES! I hope MannKind sticks SNY hard! C'mon NOVO, Lilly or JnJ...bet they'd like to stick it to SNY also after years of Lantus dominance. Time for the French to get f----d but good.
|
|
|
Post by mindovermatter on Jan 5, 2016 15:50:22 GMT -5
As others have said, no rose colored glasses today. This hurts. Bad. Now if I were Al Mann, I would be seething angry. Sanofi sandbagged him and Mannkind shareholders. Plain and simple. So I have a new dream. First, we survive. I think we will with Al Mann's help. Time to sue Sanofi for not living up to their end of the deal. Second, if we survive, then there is a new mission. A new dream. A new hope. TAKE MARKET SHARE FROM SANOFI! I hope we stick it to them but good over the years. I hope Mannkind becomes an ever present nightmare for Sanofi. I have a dream.... What do you sue Sanofi for? Breach of contract? Good luck in proving that. But let's say Mannkind does. How much money, time and effort will it take? Mannkind doesn't have a lot of resources or money for that. Sanofi can drag this out as long as they need to until Mannkind declares bankruptcy. Many of you are so emotional over the news today that you no longer are thinking rationally.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 5, 2016 15:53:24 GMT -5
Docfrezza stated Afrezza is not being handed over back to MNKD for 6 months. This stock is done. If they were sand bagging before what do you think they are going to do now. Hopefully I can sell my position on some short covering pops.
|
|
|
Post by harryx1 on Jan 5, 2016 15:53:50 GMT -5
Any resident Afrezza users interested?
|
|
|
Post by liane on Jan 5, 2016 17:01:47 GMT -5
Docfrezza stated Afrezza is not being handed over back to MNKD for 6 months. This stock is done. If they were sand bagging before what do you think they are going to do now. Hopefully I can sell my position on some short covering pops. Per the cc, the rights are now non-exclusive - so MNKD is free to take Afrezza where they wish - NOW!
|
|
|
Post by savzak on Jan 5, 2016 17:05:54 GMT -5
Docfrezza stated Afrezza is not being handed over back to MNKD for 6 months. This stock is done. If they were sand bagging before what do you think they are going to do now. Hopefully I can sell my position on some short covering pops. Per the cc, the rights are now non-exclusive - so MNKD is free to take Afrezza where they wish - NOW! Exactly and presumably it can be priced by MNKD or any new licensee however they wish. SNY should have no say in the commercialization terms of any new licensee. In theory, MNKD could put SNY out of the Afrezza business even quicker than SNY expects if a new licensee undercuts SNY's pricing.
|
|
|
Post by mnholdem on Jan 5, 2016 17:37:40 GMT -5
13.3 Rights on Termination Other than Termination By Sanofi for Cause. This Section 13.3 shall apply and shall only apply upon the termination of this Agreement by MannKind pursuant to Section 12.2 or Section 12.4, or by Sanofi pursuant to Section 12.3(a):
(d) Rights Become Non-Exclusive. Notwithstanding any other provision of this Agreement, following the effective date of termination and during the Wind-down Period, Sanofi’s and its Affiliates’ rights with respect to Product in the Field in the Territory shall be non-exclusive, and, without limiting the foregoing, MannKind shall have the right to engage one or more other distributors and/or licensees of Product in the Field in the Territory.
---
"pursuant to Section 12.3(a)' refers to the following:
12.3 Additional Sanofi Termination Rights.
(a) If, at any time on or after January 1, 2016, Sanofi determines in good faith that Commercialization of Product is no longer economically viable in the United States, then Sanofi may terminate this Agreement in its entirety upon delivery of at least ninety (90) days’ prior written notice to MannKind.
www.sec.gov/Archives/edgar/data/899460/000119312514406347/d783199dex101.htm
My question would be when is the effective date of termination?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 5, 2016 17:38:04 GMT -5
Docfrezza stated Afrezza is not being handed over back to MNKD for 6 months. This stock is done. If they were sand bagging before what do you think they are going to do now. Hopefully I can sell my position on some short covering pops. Per the cc, the rights are now non-exclusive - so MNKD is free to take Afrezza where they wish - NOW! When is the end of the notice peroid I htought it was july
|
|
|
Post by mnholdem on Jan 5, 2016 17:41:03 GMT -5
No later than July 4, 2016.
harryx1 posted an internal memo to Sanofi reps stating, as I recall, that the termination date will be in April.
|
|
|
Post by me on Jan 5, 2016 17:43:21 GMT -5
13.3 Rights on Termination Other than Termination By Sanofi for Cause. This Section 13.3 shall apply and shall only apply upon the termination of this Agreement by MannKind pursuant to Section 12.2 or Section 12.4, or by Sanofi pursuant to Section 12.3(a):
(d) Rights Become Non-Exclusive. Notwithstanding any other provision of this Agreement, following the effective date of termination and during the Wind-down Period, Sanofi’s and its Affiliates’ rights with respect to Product in the Field in the Territory shall be non-exclusive, and, without limiting the foregoing, MannKind shall have the right to engage one or more other distributors and/or licensees of Product in the Field in the Territory.
---
"pursuant to Section 12.3(a)' refers to the following:
12.3 Additional Sanofi Termination Rights.
(a) If, at any time on or after January 1, 2016, Sanofi determines in good faith that Commercialization of Product is no longer economically viable in the United States, then Sanofi may terminate this Agreement in its entirety upon delivery of at least ninety (90) days’ prior written notice to MannKind.
www.sec.gov/Archives/edgar/data/899460/000119312514406347/d783199dex101.htm
My question would be when is the effective date of termination?
My question would be does the "Wind-down Period" begin with the date of notice of termination?
|
|
|
Post by savzak on Jan 5, 2016 17:45:03 GMT -5
13.3 Rights on Termination Other than Termination By Sanofi for Cause. This Section 13.3 shall apply and shall only apply upon the termination of this Agreement by MannKind pursuant to Section 12.2 or Section 12.4, or by Sanofi pursuant to Section 12.3(a):
(d) Rights Become Non-Exclusive. Notwithstanding any other provision of this Agreement, following the effective date of termination and during the Wind-down Period, Sanofi’s and its Affiliates’ rights with respect to Product in the Field in the Territory shall be non-exclusive, and, without limiting the foregoing, MannKind shall have the right to engage one or more other distributors and/or licensees of Product in the Field in the Territory.
---
"pursuant to Section 12.3(a)' refers to the following:
12.3 Additional Sanofi Termination Rights.
(a) If, at any time on or after January 1, 2016, Sanofi determines in good faith that Commercialization of Product is no longer economically viable in the United States, then Sanofi may terminate this Agreement in its entirety upon delivery of at least ninety (90) days’ prior written notice to MannKind.
www.sec.gov/Archives/edgar/data/899460/000119312514406347/d783199dex101.htm
My question would be when is the effective date of termination?
I don't currently have access to the rest of the agreement, but it must be the date of notice. Otherwise, the reference to the wind-down period and to Sanofi's rights being non-exclusive would make no sense. After the wind-down, Sanofi will have no rights, so they can not be non-exclusive. The effective date of termination must be the notice date.
|
|
|
Post by slugworth008 on Jan 5, 2016 19:58:15 GMT -5
Docfrezza stated Afrezza is not being handed over back to MNKD for 6 months. This stock is done. If they were sand bagging before what do you think they are going to do now. Hopefully I can sell my position on some short covering pops. Adios - and happy trails to you. This stock is far from done IMO. But then again I have Maui Jim rose colored glasses and Ralph Lauren blinders on. Peace out.
|
|
|
Post by slugworth008 on Jan 5, 2016 20:02:26 GMT -5
As others have said, no rose colored glasses today. This hurts. Bad. Now if I were Al Mann, I would be seething angry. Sanofi sandbagged him and Mannkind shareholders. Plain and simple. So I have a new dream. First, we survive. I think we will with Al Mann's help. Time to sue Sanofi for not living up to their end of the deal. Second, if we survive, then there is a new mission. A new dream. A new hope. TAKE MARKET SHARE FROM SANOFI! I hope we stick it to them but good over the years. I hope Mannkind becomes an ever present nightmare for Sanofi. I have a dream.... What do you sue Sanofi for? Breach of contract? Good luck in proving that. But let's say Mannkind does. How much money, time and effort will it take? Mannkind doesn't have a lot of resources or money for that. Sanofi can drag this out as long as they need to until Mannkind declares bankruptcy. Many of you are so emotional over the news today that you no longer are thinking rationally. Really?, just the talk of a lawsuit will damage SNY with other companies they may want to partner with. SNY has taken a bit hit in credibility IMO. I would think there are law firms out there that would do a little pro-bono work and that SNY would payoff just to shut them up and keep out of the spotlight. IMO - Glad your not so emotional - perhaps because you weren't that invested in the first place.
|
|